Table 1.
ID | Age | Sex | Clinical status | WBC/µL | Lymphocyte (%) | Abnormal lymphocyte (%) | Provirus DNA copies/1000 PBMCs | Plasma HTLV‐1 antibody titer † |
---|---|---|---|---|---|---|---|---|
#211 | 20s | F | AC | 4500 | 34 | 0 | 33 | >8192 |
#213 | 50s | F | sATL ‡ | 7500 | 36 | 8 | 200 | 4096 |
#215 | 20s | M | AC | 8000 | 55 | 0 | 13 | 2048 |
#216 | 70s | F | AC | 4200 | 31 | 3 | 39 | >8192 |
#217 | 70s | F | AC | 6800 | 51 | 0 | 14 | >8192 |
#218 | 50s | F | AC | 7500 | 55 | 0 | <1 | 1024 |
#219 | 60s | F | AC | 7200 | 43 | 0 | <1 | 1024 |
#220 | 50s | M | sATL | 4800 | 28 | 13 | 277 | >8192 |
#223 | 60s | M | AC | 4200 | 26 | 0 | <1 | 1024 |
#226 | 50s | M | AC | 5700 | 38 | 0 | 28 | 2048 |
#228 | 60s | M | AC | 5900 | 59 | 0 | <1 | 256 |
#232 | 30s | F | AC | 5800 | 46 | 0 | <1 | >8192 |
#236 | 30s | F | AC | 6500 | 39 | 0 | 22 | >8192 |
#238 | 60s | F | AC | 5700 | 51 | 0 | 2 | 1024 |
#243 | 50s | F | AC | 4100 | 58 | 0 | 3 | 2048 |
#244 | 50s | F | AC | 4900 | 27 | 3 | 63 | 1024 |
#245 | 40s | F | AC | 5000 | 46 | 1 | 58 | 1024 |
#246 | 50s | M | AC | 4600 | 37 | 0 | 2 | >8192 |
#251 | 60s | M | AC | 4800 | 50 | 0 | 2 | 2048 |
#252 | 50s | F | sATL | 4100 | 38 | 11 | 207 | >8192 |
#258 | 60s | M | AC | 6400 | 30 | 3 | 8 | 256 |
#263 | 60s | M | AC | 3900 | 49 | 2 | 1 | 2048 |
#264 | 50s | F | AC | 3000 | 37 | 0 | <1 | 256 |
#265 | 60s | F | sATL § | 4700 | 38 | 1 | 2 | 2048 |
#277 | 50s | F | AC | 4100 | 29 | 0 | <1 | 256 |
Measured by a particle agglutination method.
Diagnosed as sATL because of increased abnormal lymphocyte number, although the infected cells were polyclonal.
Diagnosed as sATL because of the presence of skin lesions.
HTLV‐1, human T‐cell leukemia virus type‐1; ACs, asymptomatic HTLV‐1 carriers; ATL, adult T‐cell leukemia; sATL, smoldering‐type ATL; PMBC, peripheral blood mononuclear cell; WBC, white blood cell.